Liraglutide for NASH/NAFLD

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|3|269-278

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.3, 2015-03, pp. : 269-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: call to screen for NAFLD and NASH in psoriasis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 492-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1367-1372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liraglutide: A New Option for the Treatment of Obesity

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 926-934

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lean NAFLD: A not so benign condition?

By  

Hepatology Communications, Vol. 2, Iss. 1, 2018-01 ,pp. : 5-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 195-203

Bentham Science Publishers

Access to resources Recommend Favorite